- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.03. | EMA panel endorses AI for MASH clinical trials | ||
| 21.03. | AZ builds in China, as J&J ramps up its US investments | ||
| 21.03. | Fabhalta is first FDA-approved therapy for rare disease C3G | ||
| 21.03. | J&J adds to IL-23 options in Crohn's after FDA approval | ||
| 21.03. | Alnylam joins three-way contest in ATTR cardiomyopathy | ||
| 20.03. | Synchron, Nvidia showcase AI for brain-computer interfaces | ||
| 20.03. | CARGO offloads staff after abandoning lead CAR-T | ||
| 20.03. | Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug | ||
| 20.03. | Gantenerumab 'shows sign of preventing Alzheimer's dementia' | ||
| 20.03. | UK is becoming an 'outlier' for pharma, hitting investment | ||
| 19.03. | Roche taps Oxford BioTherapeutics for cancer drug discovery | ||
| 19.03. | Google promises new AI models for drug discovery | ||
| 19.03. | J&J's nipocalimab fast-tracked for Sjogren's disease | ||
| 19.03. | Sarepta slumps on Elevidys patient death | ||
| 19.03. | Novartis sheds staff as Entresto patent expiry looms | ||
| 18.03. | EnteroBiotix cues up larger trial of microbiome IBS therapy | ||
| 18.03. | Novo Nordisk returns to ABPI fold after two-year suspension | ||
| 18.03. | Sofinnova closes new fund and backs a trio of new biotechs | ||
| 18.03. | AstraZeneca buys cell therapy biotech for up to $1bn | ||
| 18.03. | Vertanical's cannabis-based painkiller hits target in trials | ||
| 17.03. | Latigo raises $150m for non-opioid painkiller push | ||
| 17.03. | Taiho snaps up ADC partner Araris for up to $1.14bn | ||
| 17.03. | Eisai to buy "dementia ecosystem" partner EcoNaviSta | ||
| 14.03. | FDA chooses flu vaccine strains despite cancelled meeting | ||
| 14.03. | NHS England 'has lost control of health service', says BMA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
